Literature DB >> 18446462

Optimization studies on design and evaluation of orodispersible pediatric formulation of indomethacin.

Jashanjit Singh1, Anil K Philip, Kamla Pathak.   

Abstract

In the present study, the aim was to optimize an orodispersible formulation of indomethacin using a combined approach of subliming agent and superdisintegrant. The tablets were made by non-aqueous wet granulation technique with superdisintegrant incorporated both intragranularly and extragranularly. A 2(3) factorial design was used to investigate the effects amount of subliming agents namely camphor and ammonium bicarbonate and taste masking and soothening hydrophilic agent mannitol as independent variables and disintegration time and crushing strength as dependent responses. The volatilization time of eight hours at 50 degrees C was optimized by conducting solid-state kinetic studies of optimized formulations. Optimized orodispersible tablets were evaluated for wetting time, water absorption ratio, porosity and in vitro and in vivo disintegration tests. Results show that higher levels of camphor and mannitol and a lower level of ammonium bicarbonate is desirable for orodispersion. Scanning electron microscopy (SEM) revealed the porous surface morphology and kinetic digital images substantiated the orodispersible property. Differential Scanning Calorimetry (DSC) studies exhibited physiochemical compatibility between indomethacin and various excipients used in the tablet formulation. Stability studies carried out as per ICH Q(1) A guidelines suggested the stable formulations for the tested time period of 6 months. The systematic approach of using subliming and disintegrating agents helped in achieving a stable, optimized orodispersible formulation, which could be industrially viable.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18446462      PMCID: PMC2976910          DOI: 10.1208/s12249-007-9018-4

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  5 in total

1.  Fast dispersible ibuprofen tablets.

Authors:  Simone Schiermeier; Peter Christian Schmidt
Journal:  Eur J Pharm Sci       Date:  2002-04       Impact factor: 4.384

2.  Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity.

Authors:  Y Bi; H Sunada; Y Yonezawa; K Danjo; A Otsuka; K Iida
Journal:  Chem Pharm Bull (Tokyo)       Date:  1996-11       Impact factor: 1.645

3.  A new tablet disintegrating agent: cross-linked polyvinylpyrrolidone.

Authors:  S S Kornblum; S B Stoopak
Journal:  J Pharm Sci       Date:  1973-01       Impact factor: 3.534

4.  Evaluation of rapidly disintegrating tablets prepared by a direct compression method.

Authors:  Y X Bi; H Sunada; Y Yonezawa; K Danjo
Journal:  Drug Dev Ind Pharm       Date:  1999-05       Impact factor: 3.225

5.  Formulation design and optimization of mouth dissolve tablets of nimesulide using vacuum drying technique.

Authors:  Mukesh Gohel; Madhabhai Patel; Avani Amin; Ruchi Agrawal; Rikita Dave; Nehal Bariya
Journal:  AAPS PharmSciTech       Date:  2004-04-26       Impact factor: 3.246

  5 in total
  10 in total

1.  Optimization and in vivo pharmacokinetic study of a novel controlled release venlafaxine hydrochloride three-layer tablet.

Authors:  Ahmed A Aboelwafa; Emad B Basalious
Journal:  AAPS PharmSciTech       Date:  2010-06-08       Impact factor: 3.246

2.  Pediatric Dispersible Tablets: a Modular Approach for Rapid Prototyping.

Authors:  Jonas Buck; Jörg Huwyler; Peter Kühl; Angela Dischinger
Journal:  Pharm Res       Date:  2016-06-01       Impact factor: 4.200

3.  Design of Isoniazid Smart Nanogel by Gamma Radiation-Induced Template Polymerization for Biomedical Application.

Authors:  Samia M Omar; Nabila A Maziad; Nourhan M El-Tantawy
Journal:  Pharm Res       Date:  2017-06-15       Impact factor: 4.200

4.  Difficulties swallowing solid oral dosage forms in a general practice population: prevalence, causes, and relationship to dosage forms.

Authors:  Julia T Schiele; Renate Quinzler; Hans-Dieter Klimm; Markus G Pruszydlo; Walter E Haefeli
Journal:  Eur J Clin Pharmacol       Date:  2012-09-29       Impact factor: 2.953

5.  Development of a Novel Bilosomal System for Improved Oral Bioavailability of Sertraline Hydrochloride: Formulation Design, In Vitro Characterization, and Ex Vivo and In Vivo Studies.

Authors:  Aliaa Ismail; Mohammed Teiama; Basma Magdy; Wedad Sakran
Journal:  AAPS PharmSciTech       Date:  2022-07-08       Impact factor: 4.026

6.  Fast disintegrating tablets: Opportunity in drug delivery system.

Authors:  Ved Parkash; Saurabh Maan; Shiv Kumar Yadav; Vikas Jogpal
Journal:  J Adv Pharm Technol Res       Date:  2011-10

7.  Formulation Development and evaluation of fast disintegrating tablets of Lamotrigine using liqui-solid technique.

Authors:  Poluri Koteswari; Suvarnala Sunium; Puttugunta Srinivasababu; Govada Kishore Babu; Pinnamraju Durga Nithya
Journal:  Int J Pharm Investig       Date:  2014-10

8.  Full factorial design for optimization, development and validation of HPLC method to determine valsartan in nanoparticles.

Authors:  Lalit Kumar; M Sreenivasa Reddy; Renuka S Managuli; Girish Pai K
Journal:  Saudi Pharm J       Date:  2015-03-03       Impact factor: 4.330

9.  Pharmaceutical Cocrystal of Piroxicam: Design, Formulation and Evaluation.

Authors:  Prabhakar Panzade; Giridhar Shendarkar; Sarfaraj Shaikh; Pavan Balmukund Rathi
Journal:  Adv Pharm Bull       Date:  2017-09-25

10.  Optimal Design, Characterization and Preliminary Safety Evaluation of an Edible Orodispersible Formulation for Pediatric Tuberculosis Pharmacotherapy.

Authors:  Nyaradzo Matawo; Oluwatoyin A Adeleke; James Wesley-Smith
Journal:  Int J Mol Sci       Date:  2020-08-10       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.